Cargando…

Avapritinib-induced photo-aggravated cutaneous reaction

Detalles Bibliográficos
Autores principales:	Dadrass, Farinoosh, Han, Joohee, Gaddis, Kevin J., Swick, Marki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818934/ https://www.ncbi.nlm.nih.gov/pubmed/35146099 http://dx.doi.org/10.1016/j.jdcr.2021.12.019

Ejemplares similares

Avapritinib for Cutaneous Mastocytosis
por: LEE, Hannah, et al.
Publicado: (2021)

Palpable purpuric eruption mimicking vasculitis following avapritinib
por: Mohammed, Taha Osman, et al.
Publicado: (2022)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma
por: Cocorocchio, Emilia, et al.
Publicado: (2020)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
por: Dadrass, Farinoosh, et al.
Publicado: (2022)

Photosensitivity From Avapritinib: Pharamacovigilance Analysis
por: Venkatakrishnan, Ajit, et al.
Publicado: (2022)

The Role of Avapritinib for the Treatment of Systemic Mastocytosis
por: Sumbly, Vikram, et al.
Publicado: (2021)

Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report()
por: Drom, Claire, et al.
Publicado: (2022)

Disseminated Langerhans cell histiocytosis in a 51-year-old man with cutaneous involvement and multiple endocrinopathies
por: Voller, Lindsey M., et al.
Publicado: (2019)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
por: Mannelli, Francesco, et al.
Publicado: (2023)

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
por: Cavazos, Karla, et al.
Publicado: (2022)

Large cutaneous apocrine carcinoma occurring on right thigh aggravated after moxa treatment
por: Choi, In Ho, et al.
Publicado: (2015)

Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
por: DeAngelo, Daniel J., et al.
Publicado: (2021)

Synthesis of some new porphyrins and their metalloderivatives as potential sensitizers in photo-dynamic therapy
por: Rostami, Mahboubeh, et al.
Publicado: (2015)

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
por: Joseph, Cissimol P., et al.
Publicado: (2021)

Avapritinib in advanced gastrointestinal stromal tumor: case series and review of the literature from a tertiary care center in India
por: Verma, Saurav, et al.
Publicado: (2021)

Combination of Type I and II tyrosine kinase inhibitors—avapritinib and sunitinib—in refractory gastrointestinal stromal tumor after failure to multi-line therapy: a case report
por: Guo, Xiaodan, et al.
Publicado: (2022)

Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment
por: Ye, Shuai, et al.
Publicado: (2021)

Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
por: Kang, Yoon-Koo, et al.
Publicado: (2021)

Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia
por: Sandow, Lyndsey, et al.
Publicado: (2023)

Cutaneous drug reaction with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2009)

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
por: Gotlib, Jason, et al.
Publicado: (2021)

Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
por: George, Suzanne, et al.
Publicado: (2021)

Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine
por: Massot, Andreu, et al.
Publicado: (2014)

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
por: Reiter, A., et al.
Publicado: (2022)

The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation
por: Trullas-Jimeno, A., et al.
Publicado: (2021)

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)

Sweet syndrome-like cutaneous drug reaction
por: da Silva, Lissandra Melati, et al.
Publicado: (2017)

Severe Cutaneous Reaction to Latanoprost Eye Drops
por: Yip, Ivan Yeu Ming, et al.
Publicado: (2018)

CD20(+) cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literature
por: Tschetter, Amanda J., et al.
Publicado: (2020)

Hypothyroidism-induced Reversible Encephalopathy as a Cause of Aggravation of Parkinsonism and Myoclonus in Parkinson’s Disease
por: Ehm, Gwanhee, et al.
Publicado: (2017)

Photo-induced defluorination acyl fluoride exchange as a fluorogenic photo-click reaction for photo-affinity labeling
por: Deng, Lijun, et al.
Publicado: (2023)

Lepra Reaction with Lucio Phenomenon Mimicking Cutaneous Vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2014)

Cutaneous granulomatous reaction as the first manifestation of Hodgkin's lymphoma
por: Moreira, Catarina, et al.
Publicado: (2017)

Probable cutaneous adverse drug reaction to piroxicam in a cat
por: Young, Amanda J, et al.
Publicado: (2018)

Telmisartan aggravates pustular psoriasis
por: Keerthi, Subramaniam, et al.
Publicado: (2015)

Mitochondrial Disorder Aggravated by Metoprolol
por: Samuels, Cheryl, et al.
Publicado: (2016)

Multifocal paraganglioma, mycosis fungoides, and monoclonal B-cell lymphocytosis in association with RAD51C mutation
por: Goyal, Amrita, et al.
Publicado: (2019)

Myasthenia Gravis Aggravated by Steroid-Induced Isolated Mediastinal Tuberculous Lymphadenitis
por: Nam, Tai-Seung, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2j8eocvr3n703tjhoj16cg1642